Bradycardia with Hyperkalemia: Advanced ACLS and Clinical Simulation Guide
I. Introduction
Bradycardia is a common arrhythmia encountered in emergency and critical care settings. When bradycardia coexists with hyperkalemia, especially in patients with renal failure or missed dialysis, it presents a high-risk, rapidly evolving emergency that demands swift and protocol-driven action.
This article will guide you through:
- The pathophysiology of hyperkalemia-induced bradycardia,
- The ACLS adaptation in the presence of hyperkalemia,
- The recognition of electromechanical dissociation (EMD),
- Simulation scenarios based on real-world cases,
- And a detailed treatment algorithm.
II. Pathophysiology of Hyperkalemia and Its Cardiac Effects
Normal Physiology of Potassium
Potassium (K⁺) plays a vital role in maintaining:
- Resting membrane potential
- Cardiac action potential generation
- Electrical conduction in the myocardium
Effects of Hyperkalemia on the Heart
When serum potassium rises:
| Serum K⁺ Level (mEq/L) | ECG Findings |
| 5.5–6.5 | Peaked T waves |
| 6.5–7.5 | PR prolongation, loss of P wave |
| >7.5 | Widened QRS, sine wave, ventricular standstill |
| >9 | Asystole or PEA (pulseless electrical activity) |
III. ACLS Adaptation in Bradycardia with Hyperkalemia
Step 1: Recognize Bradycardia in the Hyperkalemic Patient
- ECG: Wide QRS, slow heart rate, peaked T waves
- Symptoms: Hypotension, confusion, syncope, chest pain
- History: Missed dialysis, renal failure, drugs (e.g., K⁺-sparing diuretics)
Always suspect hyperkalemia in bradycardic ESRD patients.
IV. Immediate Management: Stabilize, Shift, Remove Potassium
1. Membrane Stabilization – First Priority
Prevents arrhythmias by stabilizing the myocardium.
| Drug | Dose | Route | Notes |
| Calcium Gluconate 10% | 30 mL IV over 5–10 mins | IV | Peripheral line safe |
| Calcium Chloride 10% | 10 mL IV over 5–10 mins | IV | 3x stronger than gluconate – Central line only |
Both deliver ~270 mg elemental calcium.
Do not delay treatment for labs. ECG changes alone justify calcium use.
2. Shift Potassium Intracellularly
Temporarily lowers serum K⁺ while preparing for removal.
| Agent | Dose | Mechanism |
| Regular Insulin | 10 units IV push | Stimulates Na/K pump |
| Dextrose 50% (D50) | 25–50 mL IV push with insulin | Prevents hypoglycemia |
| Albuterol | 10–20 mg in 4 mL NS via nebulizer over 10 min | β2 agonist promotes K⁺ shift |
| Sodium Bicarbonate | 50 mEq IV push (optional) | Alkalosis shifts K⁺ intracellular |
3. Remove Potassium from the Body
| Method | Notes |
| Loop diuretics (e.g., furosemide) | Only if kidneys work |
| Sodium polystyrene sulfonate (Kayexalate) | Slow onset |
| Hemodialysis | Gold standard in ESRD or life-threatening hyperkalemia |
V. Transition from Bradycardia to PEA: Electromechanical Dissociation (EMD)
What is Electromechanical Dissociation?
EMD or Pseudo-PEA is when:
- ECG shows rhythm (e.g., paced, bradycardia),
- But there is no mechanical activity → no pulse, no BP.
Common in severe hyperkalemia.
VI. ACLS Algorithm Switch: From Bradycardia to PEA
When to Switch?
If monitor shows electrical activity, pacemaker is capturing, BUT no pulse or BP → treat as PEA.
PEA ACLS Protocol
- Start CPR immediately
- Epinephrine 1 mg IV q3-5 minutes
- No shocks (non-shockable rhythm)
- Search and treat reversible causes – “Hs and Ts”
- H = Hyperkalemia is #1 here
Continue calcium, insulin/dextrose, albuterol, and prepare for emergency dialysis.
VII. Understanding Calcium Gluconate vs. Calcium Chloride
| Parameter | Calcium Gluconate 10% | Calcium Chloride 10% |
| Elemental Ca²⁺ per 10 mL | ~90 mg | ~270 mg |
| Administration | Peripheral line safe | Central line preferred |
| Risk of tissue injury | Lower | High risk if extravasated |
Equivalency: 30 mL of gluconate ≈ 10 mL of chloride
VIII. Simulation Case for Medical Students
Case:A 58-year-old male with ESRD missed 2 dialysis sessions. He presents with HR 30 bpm, BP unmeasurable. Monitor shows wide QRS. External pacing applied—electrical capture achieved, but no pulse.
Management Steps:
- CPR immediately → EMD = PEA.
- Epinephrine 1 mg IV q3–5 min
- Calcium gluconate 30 mL IV over 5–10 min
- Insulin 10 units + D50 25–50 mL IV push
- Albuterol 20 mg via nebulizer
- Call for urgent dialysis.
⚠️ Electrical capture ≠ mechanical outputAlways check pulse and BP, not just the monitor.
IX. Additional Teaching Pearls for OSCE/ACLS Prep
- In hyperkalemia-induced bradycardia, atropine is rarely effective.
- Pacing without calcium stabilization is often ineffective.
- Calcium chloride is stronger but should be used via central line only.
- If no pulse after pacing = EMD → treat as PEA.
- Hyperkalemia is a reversible cause of PEA → treat the cause, not just symptoms.
X. Summary Table
| Step | Action | Why |
| 1 | Calcium Gluconate 10% 30 mL IV | Membrane stabilization |
| 2 | Insulin 10U + D50 | K⁺ shift intracellular |
| 3 | Albuterol | Additional K⁺ shift |
| 4 | Sodium Bicarbonate | In acidemia, enhances K⁺ shift |
| 5 | CPR + Epinephrine | If pulseless (PEA) |
| 6 | Hemodialysis | Definitive K⁺ removal |
Conclusion
Hyperkalemia-induced bradycardia progressing to EMD or PEA is one of the most high-stakes emergency scenarios in clinical medicine. Understanding how to shift from bradycardia protocol to full ACLS PEA protocol, while aggressively reversing hyperkalemia, can mean the difference between life and death.
Remember, electrical capture is not enough—always check for a mechanical pulse. Think fast, act faster, and always treat the underlying cause.